Chinese pharma company announces partnership with Canadian biotech firm

Sep 14, 2021 9:14 am

Chinese biopharmaceutical company Everest Medicines Ltd announced on Monday a strategic partnership with Canadian biotechnology company Providence Therapeutics Holdings Inc in an effort to develop mRNA COVID-19 vaccines.

Under the partnership, Everest is licensed rights to Providence's mRNA COVID-19 vaccine candidates in Asian emerging markets, including China, Southeast Asia and Pakistan. The two parties will also establish a broad, strategic partnership to develop mRNA products globally, leveraging Providence's cutting-edge mRNA technology platform. 


Invite your friends, colleagues and business partners to

join us to get news, analysis and database of Chinese market.

Invite Now FOR FREE >